Try our Advanced Search for more refined results

Expert Analysis

Spinoff Transaction Considerations For Biotech M&A

By Andrew Goodman, Daniel Nicholas and Seo Salimi ( June 27, 2025, 2:16 PM EDT) -- The biotech mergers and acquisitions market currently faces significant headwinds,[1] with challenges including frozen capital markets, regulatory uncertainty at the U.S. Food and Drug Administration and U.S. Department of Health and Human Services, and tariffs....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections

Law Firms

Government Agencies